§ 62J.845 — Prohibition on Withdrawal of Generic or Off-patent Drugs for Sale
Plain-Language Summary
Prohibits drug companies from pulling generic or off-patent drugs from the market to avoid price rules.
62J.845 PROHIBITION ON WITHDRAWAL OF GENERIC OR OFF-PATENT DRUGS FOR SALE.
§
Subdivision 1.Prohibition.
A manufacturer of a generic or off-patent drug is prohibited from withdrawing that drug from sale or distribution within this state for the purpose of avoiding the prohibition on excessive price increases under section 62J.842. §
Subd. 2.Notice to board and attorney general.
Any manufacturer that intends to withdraw a generic or off-patent drug from sale or distribution within the state shall provide a written notice of withdrawal to the attorney general at least 90 days prior to the withdrawal. §
Subd. 3.Financial penalty.
The attorney general shall assess a penalty of $500,000 on any manufacturer of a generic or off-patent drug that the attorney general determines has failed to comply with the requirements of this section.
History:
History: History:
2023 c 57 art 2 s 26